We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+5.55%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$5.86B
AUM Growth
+$813M
(+16%)
Cap. Flow
+$544M
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
50.44%
Holding
3,726
New
379
Increased
1,205
Reduced
834
Closed
278
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$68.1M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$66.4M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$59M |
| 4 |
Vanguard Mid-Cap ETF
VO
|
+$49.9M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$26.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$77.7M |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$5.23M |
| 3 |
WisdomTree Emerging Markets Local Debt Fund
ELD
|
+$3.78M |
| 4 |
Invesco Preferred ETF
PGX
|
+$3.67M |
| 5 |
Nuveen Municipal High Income Opportunity Fund
NMZ
|
+$2.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 6.93% |
| 2 | Financials | 4.55% |
| 3 | Technology | 3.35% |
| 4 | Industrials | 2.51% |
| 5 | Healthcare | 2.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRMN
626
Garmin
GRMN
$46.9B
| $358K | 0.01% |
7,750
-218
| -3% | -$10.3K |
|
627
Banco Santander
SAN
$194B
| $358K | 0.01% |
43,440
+3,790
| +10% | +$30.1K |
|
|
PCN
628
PIMCO Corporate & Income Strategy Fund
PCN
$870M
| $355K | 0.01% |
+22,497
| New | +$372K |
|
629
MaxLinear
MXL
$6.49B
| $354K | 0.01% |
+33,905
| New | +$292K |
|
630
Genesis Energy
GEL
$1.84B
| $353K | 0.01% |
6,713
+875
| +15% | +$44.3K |
|
631
AstraZeneca
AZN
$263B
| $352K | 0.01% |
5,924
+1,538
| +35% | +$83.5K |
|
|
WP
632
DELISTED
Worldpay, Inc.
WP
| $352K | 0.01% |
10,790
+5,000
| +86% | +$145K |
|
633
GameStop
GME
$9.5B
| $348K | 0.01% |
28,248
+2,768
| +11% | +$35.5K |
|
634
NNN REIT
NNN
$9.39B
| $345K | 0.01% |
11,360
-500
| -4% | -$16.2K |
|
|
HIX
635
Western Asset High Income Fund II
HIX
$352M
| $342K | 0.01% |
37,926
+3,806
| +11% | +$35.1K |
|
|
CNL
636
DELISTED
CLECO CRP (HOLDING CO)
CNL
| $342K | 0.01% |
7,330
+4,019
| +121% | +$185K |
|
637
Crocs
CROX
$6.69B
| $341K | 0.01% |
21,400
+600
| +3% | +$7.99K |
|
638
Schwab International Equity ETF
SCHF
$65.6B
| $341K | 0.01% |
21,646
+17,210
| +388% | +$268K |
|
|
HOT
639
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $341K | 0.01% |
4,289
+353
| +9% | +$25.8K |
|
640
Edwards Lifesciences
EW
$47.6B
| $340K | 0.01% |
30,984
-8,898
| -22% | -$100K |
|
641
Wabtec
WAB
$51.1B
| $336K | 0.01% |
4,521
| – | – |
|
642
Globe Life
GL
$13.5B
| $335K | 0.01% |
6,440
-150
| -2% | -$7.48K |
|
643
Adams Diversified Equity Fund
ADX
$3.17B
| $333K | 0.01% |
25,447
+22,074
| +654% | +$281K |
|
644
Cooper Companies
COO
$13.7B
| $333K | 0.01% |
10,740
+600
| +6% | +$19.1K |
|
645
FMC
FMC
$1.42B
| $331K | 0.01% |
5,059
-81
| -2% | -$5.14K |
|
646
Oaktree Specialty Lending
OCSL
$1.03B
| $331K | 0.01% |
11,926
+8,259
| +225% | +$244K |
|
647
Vanguard FTSE Europe ETF
VGK
$30B
| $331K | 0.01% |
5,634
+1,173
| +26% | +$66.1K |
|
|
CPHD
648
DELISTED
Cepheid Inc
CPHD
| $330K | 0.01% |
7,070
| – | – |
|
|
SGEN
649
DELISTED
Seagen Inc. Common Stock
SGEN
| $329K | 0.01% |
8,250
+7,951
| +2,659% | +$324K |
|
650
Cleveland-Cliffs
CLF
$6.81B
| $326K | 0.01% |
12,430
-506
| -4% | -$12.5K |
|
Similar funds
Creative Planning's Q4 2013 Portfolio in Review
As of Q4 2013, Creative Planning held 3,726 positions worth $5.86B, up 16% from $5.04B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Creative Planning deployed $544M of net new capital in Q4 2013, opening 379 new positions and adding to 1,205 existing holdings. Its largest new stake was Allergan plc: 7,924 shares worth $1.33M.
By sector, the portfolio is most concentrated in Energy at 6.9% of assets, up from 6.3% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vanguard Intermediate-Term Corporate Bond ETF, an estimated $77.7M trimmed.
- Creative Planning's largest Q4 2013 buy was Allergan plc: 7,924 shares worth $1.33M.
- Creative Planning added most to Vanguard FTSE Developed Markets ETF in Q4 2013, an estimated $68.1M increase.
- Creative Planning's biggest Q4 2013 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $77.7M.
- Creative Planning fully exited Pioneer Municipal High Income Advantage Fund in Q4 2013, selling an estimated $1.95M.
- Creative Planning's ten largest holdings make up 50% of its $5.86B portfolio in Q4 2013.
- Creative Planning opened 379 new positions and closed 278 in Q4 2013.
- Creative Planning's portfolio value rose 16% quarter-over-quarter to $5.86B.
Based on Creative Planning's 13F filing for Q4 2013, filed 6 Jan 2014.